SmartGut

See the following -

Are We Ready for Consumer Microbiome Testing?

Juliet Preston | MedCity News | November 9, 2016

Some people collect stamps. uBiome has a different area of interest. Since 2012, the San Francisco, California, startup has received and analyzed nearly 100,000 stool samples from customers trying to understand the unique population of microorganisms that call their body ‘home.’ It’s now preparing to scale-up and diversify its testing options, with the help a $15.5 million Series B funding round that was announced in early November. An alum of the Y Combinator, uBiome has grand plans. But is the microbiome science really there?...

Read More »

uBiome Awards Microbiome Impact Grant to Explore Effects of Heavy Drinking and Smoking on Oral Microbiome

Press Release | uBiome | December 3, 2016

Microbial genomics leader uBiome is awarding in-kind scientific grants to ground-breaking microbiome studies. A microbiome impact grant award has been made to Dr. Renato Polimanti of Yale University School of Medicine, who will study the effect of heavy smoking and drinking on the oral microbiome. Grant proposals have been vetted by the company’s scientific review committee. Dr. Polimanti is a genetic epidemiologist working in the Division of Human Genetics of the Department of Psychiatry at Yale University School of Medicine...

Read More »

uBiome CEO Dr. Jessica Richman to Deliver Opening Keynote at American Medical Informatics Association Symposium

Press Release | uBiome | November 11, 2016

Jessica Richman, PhD, co-founder and CEO of the leading microbial genomics company, uBiome, will present the opening keynote address at the 2016 American Medical Informatics Association’s (AMIA) Annual Symposium, to be held in Chicago from November 12 - 16. The AMIA and its members aim to transform healthcare through trusted science, education, and practice in biomedical and health informatics. Jessica Richman, PhD, will join two other keynote speakers at the AMIA Symposium – Patricia Flatley Brennan, RN, PhD, Director of the NIH National Library of Medicine in Bethesda, Maryland and Eric Horvitz, MD, PhD, Technical Fellow and Director of the Microsoft Research Lab in Redmond...

Read More »

uBiome Raises $22M, Announces New DNA-Sequencing Microbiome Screening Test

Heather Mack | Mobi Health News | November 2, 2016

San Francisco-based uBiome, which makes a direct-to-consumer microbial genomic testing kit, has closed on a $22 million Series B funding round, led by 8VC with additional funding from Slow Ventures, Stanford’s StartX Fund and various angel investors. The funding will be used to deploy uBiome’s new testing kit, SmartGut, a sequencing-based clinical microbiome screening test. With an at-home collection kit, SmartGut aims to give individuals and their doctors access to a comprehensive screening test to weed out important microorganisms (which can only be detected through DNA sequencing) that could be causing health distress...

Read More »

uBiome Reveals Details of Clinical Screening Test for Gut Health

Press Release | uBiome | November 3, 2016

Leading microbial genomics company uBiome has released a preprint of a publication submitted for peer review, entitled “16S rRNA Gene Sequencing as a Clinical Diagnostic Aid for Gastrointestinal-related Condition.” Details are available to the public in a preprint on the online archive BioRxiv. The pre-print comes alongside the announcement of the world’s first sequencing-based clinical microbiome test, SmartGut™. SmartGut™ enables physicians and patients to access a comprehensive microbiome screening test with a simple, at-home sample collection, to identify important commensal and pathogenic microorganisms...

Read More »

UCSF Researcher to Investigate Diabetes and the Microbiome in Filipino Populations with uBiome Microbiome Impact Grant

Press Release | uBiome | December 26, 2016

Microbial genomics leader uBiome has awarded a Microbiome Impact Grant to Dr. Mark Seielstad of the University of California, San Francisco. Dr. Seielstad will investigate how patients’ risk of developing type 2 diabetes is affected by where they live. In partnership with the Philippine Genome Center, Dr. Seielstad will study the gut microbiome of Filipino type 2 diabetes patients in Manila and San Francisco, comparing them with an equivalent number of healthy control subjects in each city...

Read More »